Cardiovascular risk markers in hemodialysis patients

被引:7
|
作者
Urso, S [1 ]
Garozzo, M [1 ]
Milone, F [1 ]
Battaglia, G [1 ]
机构
[1] Osped S Matra & S Venera, Unita Operat Nefrol & Dialisi, Acireale, CT, Italy
来源
关键词
homocysteine; troponin I; CK-MB mass; ESRD; HDF on-line; hemodialysis;
D O I
10.1177/039139880402701212
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cardiovascular events are the main cause of death in hemodialysis patients. Nevertheless, acute myocardial intarction may be misdiagnosed in Uremic patients, because typical markers have a high rate of false positivity. A recent two-year prospective study showed that predialytic high serum concentrations of troponin T and CK-MB mass were associated with high mortality, cardiac mortality, myocardial infarction and unstable angina (MACEs). We studied 16 uremic patients (13 M; 3 W) on standard HD and 6 patients (4 M; 2 W) on on-line HDF, who had been taking folic acid for at least three months. Patients who suffered from acute or chronic cardiac ischemic disease were excluded. Anthropometric parameters, pre and post-dialytic pH, HCO3 and electrolytes did not differ between the two groups. Kt/V and URR % were lower in conventional HD vs on-line HDF (p<0.04; p<0.04). ORR % was strongly elevated in on-line HDF compared with HD (p<0.005). In conventional HD, ORR % was directly correlated with Kt/V and URR % (r = 0.49, p<0.04; r = 0.48, p<0.04, respectively). Even in on-line HDF ORR % was directly correlated with Kt/V and URR % (r = 0.79, p<0.04; r = 0. 76, p<0.05, respectively). Troponin I and CK-MB mass were not significantly different in pre vs post-dialysis, both in standard HD and on-line HDF Nevertheless, in standard HD postdialytic troponin I correlated with serum sodium concentration (r = 0.93, p < 0.000), potassium (r = 0,67, p < 0.004) and serum chlorine (r = 0.92, p < 0.92, p < 0.000). CK-MB mass showed a correlation with serum chlorine (r = 0.49, p < 0.05). Postdialytic CK-MB mass correlated with serum potassium in on-line HDF (r = 0.83, p < 0.03). Our data suggest that hemodialytic treatments, both standard HD and on-line HDF, do not modify serum troponin I and CK-MB mass. Consequently, we can use these parameters for the diagnostic approach in acute or chronic ischemic heart disease in hemodialysis patients.
引用
收藏
页码:1083 / 1090
页数:8
相关论文
共 50 条
  • [1] Homocysteine and cardiovascular risk in hemodialysis patients
    Arsova, V
    Lavcanska, J
    [J]. CLINICA CHIMICA ACTA, 2005, 355 : S305 - S305
  • [2] Markers of oxidative stress linked to increased risk of cardiovascular diseases in chronic hemodialysis patients.
    Pincemail, J
    Bovy, C
    Chapelle, JP
    Gielen, J
    Defraigne, JO
    Rorive, G
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 : S113 - S113
  • [3] Cinacalcet therapy and cardiovascular risk in hemodialysis patients
    Zelaznicka, Marzena
    Kocelak, Piotr
    Glinianowicz, Magdalena Olszanecka
    Chudek, Jerzy
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 722 - 729
  • [4] Body composition and cardiovascular risk in hemodialysis patients
    Nishizawa, Yoshiki
    Shoji, Tetsuo
    Ishimura, Eiji
    [J]. JOURNAL OF RENAL NUTRITION, 2006, 16 (03) : 241 - 244
  • [5] Risk factors for cardiovascular hospitalization in hemodialysis patients
    Vaiciuniene, Ruta
    Kuzminskis, Vytautas
    Ziginskiene, Edita
    Petruliene, Kristina
    [J]. MEDICINA-LITHUANIA, 2010, 46 (08): : 544 - 549
  • [6] PITFALLS IN ASSESSMENT OF CARDIOVASCULAR RISK IN HEMODIALYSIS PATIENTS
    Teplyuk, Daria
    Fominikh, Natalia
    Strugailo, Ewgenii
    Zulkarnaev, Aleksei
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [7] Cardiovascular risk in hemodialysis patients: A mechanistic approach
    House, A. A.
    Ronc, C.
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (11): : 1020 - 1027
  • [8] Impact of cytokine genotype on cardiovascular surrogate markers in hemodialysis patients
    Yilmaz, Rahmi
    Altun, Bulent
    Ozer, Necla
    Hazirolan, Tuncay
    Turgan, Cetin
    [J]. RENAL FAILURE, 2010, 32 (07) : 806 - 816
  • [9] Cardiovascular Biological Risk Markers In Patients With COPD
    Rodriguez Gonzalez-Moro, J. M.
    de Lucas-Ramos, P.
    Verde Rello, Z.
    Izquierdo Alonso, J. L.
    Bellon Cano, J. M.
    Santiago Dorrego, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [10] Parathyroid glands hyperplasia and cardiovascular risk in hemodialysis patients
    Biassoli, Erika
    Petrucci, Ilaria
    Meola, Mario
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 241 - 241